Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases

• Published in: Nature biotechnology Vol. 42; no. 1; pp. 87 - 98
• Main Authors: Lampe, George D, King, Rebeca T, Halpin-Healy, Tyler S, Klompe, Sanne E, Hogan, Marcus I, Vo, Phuc Leo H, Tang, Stephen, Chavez, Alejandro, Sternberg, Samuel H
• Format: Journal Article
• Language: English
• Published: United States Nature Publishing Group 01.01.2024
• Subjects: CRISPR; CRISPR-Cas Systems - genetics; Deoxyribonucleic acid; DNA; Gene Editing; Gene sequencing; Genome; Genome editing; Genomes; Genomics; Humans; Integration; Nucleotide sequence; Plasmids; Transcription factors; Transposases - genetics; Transposition
• ISSN: 1087-0156; 1546-1696
• DOI: 10.1038/s41587-023-01748-1

Conventional genome engineering with CRISPR-Cas9 creates double-strand breaks (DSBs) that lead to undesirable byproducts and reduce product purity. Here we report an approach for programmable integration of large DNA sequences in human cells that avoids the generation of DSBs by using Type I-F CRISPR-associated transposases (CASTs). We optimized DNA targeting by the QCascade complex through protein design and developed potent transcriptional activators by exploiting the multi-valent recruitment of the AAA+ ATPase TnsC to genomic sites targeted by QCascade. After initial detection of plasmid-based integration, we screened 15 additional CAST systems from a wide range of bacterial hosts, identified a homolog from Pseudoalteromonas that exhibits improved activity and further increased integration efficiencies. Finally, we discovered that bacterial ClpX enhances genomic integration by multiple orders of magnitude, likely by promoting active disassembly of the post-integration CAST complex, akin to its known role in Mu transposition. Our work highlights the ability to reconstitute complex, multi-component machineries in human cells and establishes a strong foundation to exploit CRISPR-associated transposases for eukaryotic genome engineering.